Clinical Trials Browser

INDUSTRY × Hematologic Neoplasms × Dasatinib × Clear all

NCT06645886 2026-03-25

A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in Combination in Participants With Advanced Hematologic Malignancies

Phase 1 Active not recruiting

Other hematologic neoplasm

Hematologic Neoplasms